Carisma Therapeutics, Inc.CARMNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank86
3Y CAGR-14.8%
5Y CAGR+7.5%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-14.8%/yr
vs +26.8%/yr prior
5Y CAGR
+7.5%/yr
Recent deceleration
Acceleration
-41.7pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $40.76M | +84.1% |
| 2024 | $22.14M | -25.0% |
| 2023 | $29.52M | -55.3% |
| 2022 | $66.00M | +20.8% |
| 2021 | $54.62M | +92.5% |
| 2020 | $28.38M | -22.6% |
| 2019 | $36.65M | +43.8% |
| 2018 | $25.49M | +26.7% |
| 2017 | $20.13M | -14.9% |
| 2016 | $23.64M | - |